Literature DB >> 22365485

Neuromuscular transmission modulation by adenosine upon aging.

Paula A Pousinha1, Alexandra M Correia, Ana M Sebastião, Joaquim A Ribeiro.   

Abstract

In infant rats adenosine A(2A) receptor-mediated modulation of neuromuscular transmission predominates over A1 receptor-mediated neuromodulation. We investigated whether aging affects this A(2A)/A(1) receptor balance. Evoked (EPPs) and miniature end plate potentials (MEPPs) were recorded from single fibers of (weeks-old) infant (3-4), young adult (12-16), older (36-38), and aged (80-90) male rat-diaphragm. The non A1/A(2A) selective agonist, 2-chloroadenosine (CADO; 30 nM) and the adenosine kinase inhibitor, iodotubericidin (ITU; 10 μM) increased mean amplitude and quantal content of EPPs in infant, young adult, and older adult rats, but not in aged rats. The facilitatory effects were prevented by the A(2A) receptor antagonist, ZM241385 (50 nM) and mimicked by the A(2A) receptor agonist, CGS21680 (10 nM). The A1 receptor agonist, 6-cyclopentyladenosine (CPA; 100 nM), decreased EPPs amplitude in all age groups. It is concluded that aging differently influences adenosine A1 receptor and A(2A) receptor-mediated presynaptic modulation of neuromuscular transmission, so that the facilitatory influence decreases upon aging, whereas the inhibitory influence remains unchanged in aged animals. The reduction of adenosine A(2A) receptors upon aging may contribute to the age-related changes in neuromuscular function.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365485     DOI: 10.1016/j.neurobiolaging.2012.01.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  5 in total

1.  Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.

Authors:  Filipe Nascimento; Ana M Sebastião; Joaquim A Ribeiro
Journal:  Purinergic Signal       Date:  2015-09-03       Impact factor: 3.765

2.  A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction.

Authors:  Ryen MacDonald; Sebastien Barbat-Artigas; Chulmin Cho; Huashan Peng; Jijun Shang; Ayman Moustaine; Salvatore Carbonetto; Richard Robitaille; Lorraine E Chalifour; Hemant Paudel
Journal:  Front Aging Neurosci       Date:  2017-08-03       Impact factor: 5.750

3.  Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.

Authors:  Mariana C Rocha; Paula A Pousinha; Alexandra M Correia; Ana M Sebastião; Joaquim A Ribeiro
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

4.  Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase.

Authors:  Filipe Nascimento; Paula A Pousinha; Alexandra M Correia; Rui Gomes; Ana M Sebastião; Joaquim A Ribeiro
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

Review 5.  Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.

Authors:  Ana M Sebastião; Nádia Rei; Joaquim A Ribeiro
Journal:  Front Pharmacol       Date:  2018-04-16       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.